«Mesothelioma remains a difficult disease to find better treatment options for, so we asked whether high - dose hemithoracic radiotherapy would decrease the rate or delay the time of local
recurrence after chemotherapy and radical surgery,» says lead author Prof Rolf A. Stahel, from the Clinic and Policlinic for Oncology, at the University Hospital Zurich, Switzerland, and current President of the European Society for Medical Oncology.
Cancer
recurrence after chemotherapy is frequently fatal.
Not exact matches
Approximately one year
after successful treatment with cytotoxic
chemotherapy and radiotherapy, patients with advanced Small Cell Lung Cancer (SCLC), which primarily affects heavy smokers, generally relapse with
recurrence of tumours that are resistant to further
chemotherapy.
These studies will investigate whether Src kinase inhibitors are best used in the adjuvant setting post-surgery or
after chemotherapy to prevent the formation of local and distant disease
recurrence.
Cancer stem cells, a type of self - renewing cell found in tumors, are of particular interest because they are the main cell type responsible for tumor progression and for resistance to
chemotherapy and radiotherapy, and therefore a major cause of tumor
recurrence after treatment.
Chemotherapy before surgery might provide a false assurance that there's no more residual cancer, whereas microscopic tumour may remain
after the surgery, leading to cancer
recurrence and possibly, death.
Patients with ER - negative, but not ER - positive, isolated locoregional
recurrence after unilateral breast cancer derive significant benefit from
chemotherapy.
Clearly a lot more work needs to be done to understand the precise cause of glioblastoma
recurrence after surgery and
chemotherapy and how to prevent it.
These results, also presented at the 2015 European Cancer Congress (ECC2015, abstract # 5BA) today, which involve the group of 1,626 patients with a
Recurrence Score between 0 and 10, demonstrated that 99.3 percent of node - negative, estrogen receptor (ER)- positive, human epidermal growth factor receptor 2 (HER2)- negative patients who met accepted guidelines for recommending chemotherapy in addition to hormonal therapy, had no distant recurrence at five years after treatment with hormonal ther
Recurrence Score between 0 and 10, demonstrated that 99.3 percent of node - negative, estrogen receptor (ER)- positive, human epidermal growth factor receptor 2 (HER2)- negative patients who met accepted guidelines for recommending
chemotherapy in addition to hormonal therapy, had no distant
recurrence at five years after treatment with hormonal ther
recurrence at five years
after treatment with hormonal therapy alone.
The woman behind the name: In 2001, Nancy R. Gelman lost a 10 - year battle with breast cancer
after multiple
recurrences and three bouts of
chemotherapy.
The first study found that adding Avastin to standard
chemotherapy (carboplatin and paclitaxel) and continuing with «maintenance» Avastin
after chemo actually slowed the time - to - disease
recurrence in women with advanced ovarian cancer.
Cardiff's last update covered his commencement of
chemotherapy (After Cancer Remission, Using Chemotherapy to Prevent Recurrence), so in this episode I'll delve into one of the novel aspects of his cance
chemotherapy (
After Cancer Remission, Using
Chemotherapy to Prevent Recurrence), so in this episode I'll delve into one of the novel aspects of his cance
Chemotherapy to Prevent
Recurrence), so in this episode I'll delve into one of the novel aspects of his cancer treatment.